Advertisement
Screener

Scilex Holding Company (SCLX) Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

Scilex Holding Company Accounts Payable

Scilex Holding Company (SCLX) had Accounts Payable of $121.05 million as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current

us-gaap:AccountsPayableCurrent · last filed 2026-08-14

  • 2026-06-30: Accounts Payable, Current $121.05M.
  • 2026-03-31: Accounts Payable, Current $101.58M.
  • 2025-12-31: Accounts Payable, Current $86.27M.
  • 2025-09-30: Accounts Payable, Current $67.36M.
Period endAccounts Payable, Current
2026-06-30$121.05M
10-Q · filed 2026-08-14
2026-03-31$101.58M
10-Q · filed 2026-05-20
2025-12-31$86.27M
10-Q · filed 2026-08-14
2025-09-30$67.36M
10-Q · filed 2025-11-14
2025-06-30$59.16M
10-Q · filed 2025-08-13
2025-03-31$57.26M
10-Q · filed 2025-05-14
2024-12-31$52.62M
10-K · filed 2026-04-10
2024-09-30$43.40M
10-Q · filed 2025-01-17
2024-06-30$41.79M
10-Q · filed 2024-08-13
2024-03-31$42.22M
10-Q · filed 2024-05-13
2023-12-31$40.95M
10-K · filed 2025-03-31
2023-09-30$32.56M
10-Q · filed 2023-11-14
2023-06-30$11.41M
10-Q · filed 2023-08-11
2023-03-31$9.82M
10-Q · filed 2023-05-12
2022-12-31$8.45M
10-K · filed 2024-03-12
2021-12-31$4.28M
10-K · filed 2023-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21